Immunology and Microbiology
Myositis
99%
Dermatomyositis
42%
Autoantibodies
34%
Polymyositis
30%
Autoimmune Disease
18%
HLA DRB1 Antigen
16%
Haplotype
14%
Single Nucleotide Polymorphism
12%
COVID-19
11%
Monospecific Antibody
10%
Vaccination Policy
10%
Autoimmune Rheumatic Disease
9%
Inclusion Body Myositis
8%
Allele
8%
Genotype
6%
Vaccine Efficacy
6%
Immunogenetics
6%
Autoantigen
6%
Tumor Necrosis Factor
5%
Immunoprecipitation
5%
Medicine and Dentistry
Myositis
100%
Dermatomyositis
22%
Diseases
20%
Autoimmune Disease
20%
COVID-19 Vaccination
16%
Inclusion Body Myositis
14%
Polymyositis
14%
Myopathy
14%
Autoantibodies
9%
Autoimmune Rheumatic Disease
8%
Disease Activity
8%
Rheumatic Disease
7%
Malignant Neoplasm
7%
COVID-19
7%
Diagnosis
7%
Symptom
6%
Adverse Event
6%
HLA-DRB1
5%
Interstitial Lung Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Myositis
52%
Autoimmune Disease
27%
Vaccination Policy
22%
Disease
17%
Adverse Event
11%
Rheumatic Disease
9%
Infection
7%
Dermatomyositis
6%
Myopathy
6%
Disease Activity
5%
Inclusion Body Myositis
5%